Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
Li C, Xu T, Zhou P, Zhang J, Guan G, Zhang H, Ling X, Li W, Meng F, Liu G, Lv L, Yuan J, Li X, Zhu M.
Li C, et al. Among authors: ling x.
BMC Complement Altern Med. 2018 Oct 16;18(1):277. doi: 10.1186/s12906-018-2329-z.
BMC Complement Altern Med. 2018.
PMID: 30326892
Free PMC article.